Archives

  • 2026-10
  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • CCCP: Defining a Mitochondrial Proton Gradient Uncoupler

    2026-01-20

    CCCP: Defining a Mitochondrial Proton Gradient Uncoupler

    Executive Summary: CCCP (carbonyl cyanide m-chlorophenyl hydrazine) is a well-characterized small molecule that disrupts mitochondrial oxidative phosphorylation by collapsing the proton motive force across the inner membrane (Yan et al., 2025). This mechanism enables researchers to study mitochondrial metabolism, dysfunction, and energy-dependent cellular processes with high specificity. APExBIO’s CCCP (SKU B5003) offers consistent purity (≈98%) and solubility parameters for reproducible results (APExBIO product page). CCCP is insoluble in water but dissolves efficiently in ethanol (≥16.23 mg/mL) and DMSO (≥20.5 mg/mL), and is not intended for in vivo or clinical use. The compound facilitates research into neurodegenerative disease models, such as Alzheimer’s disease, by enabling controlled mitochondrial disruption in cell-based assays (internal article).

    Biological Rationale

    Oxidative phosphorylation is central to cellular energy production. Mitochondria utilize the electron transport chain to establish a proton gradient across the inner membrane, driving ATP synthesis. Disruption of this proton gradient impairs ATP production and alters cellular metabolism (Yan et al., 2025). Mitochondrial dysfunction is a hallmark of several diseases, including neurodegenerative disorders like Alzheimer’s disease and metabolic syndromes. Recent deep learning studies highlight systemic mitochondrial alterations in Alzheimer’s patients, underscoring the need for dynamic, accessible tools to probe mitochondrial function (Yan et al., 2025).

    CCCP (carbonyl cyanide m-chlorophenyl hydrazine) enables researchers to model mitochondrial dysfunction by artificially collapsing the proton motive force. This function is essential for studies examining mechanistic links between energy metabolism and disease pathology. By serving as a defined mitochondrial uncoupler, CCCP is valuable for validating mitochondrial biomarkers, testing metabolic hypotheses, and optimizing imaging protocols in cell-based systems (see foundational definition).

    Mechanism of Action of CCCP (carbonyl cyanide m-chlorophenyl hydrazine)

    CCCP acts as a protonophore. The molecule binds protons in the mitochondrial intermembrane space and, due to its delocalized negative charge, traverses the lipid bilayer in its unprotonated form. Upon reaching the matrix, it releases the proton, thereby dissipating the electrochemical gradient. This uncouples electron transport from ATP synthesis, rapidly collapsing the proton motive force (advanced mechanistic insights).

    Key mechanistic features:

    • CCCP is a yellow, water-insoluble solid; it is soluble in ethanol and DMSO at ≥16.23 mg/mL and ≥20.5 mg/mL, respectively (APExBIO).
    • The compound’s anionic form efficiently crosses biological membranes due to charge delocalization.
    • By dissipating the proton gradient, CCCP blocks ATP synthesis, increases oxygen consumption, and induces characteristic mitochondrial depolarization observable by fluorescence dyes (e.g., JC-1, TMRE).
    • CCCP’s action is immediate and reversible upon washout, making it suitable for dynamic experiments.

    This mechanism is further validated in bacteriophage induction assays, where CCCP activates λ phage lytic promoters in E. coli, confirming its role as an energy poison in prokaryotic and eukaryotic systems (APExBIO).

    Evidence & Benchmarks

    • CCCP at concentrations of 1–10 μM induces rapid mitochondrial depolarization in mammalian cell lines within 5–30 minutes, measurable by loss of red fluorescence in JC-1 assays (Yan et al., 2025).
    • CCCP treatment increases mitochondrial fission and fragmentation, as quantified by deep learning-based image analysis in urine-derived stem cells from Alzheimer’s disease patients (Yan et al., 2025).
    • The B5003 CCCP product from APExBIO provides ≥98% purity, ensuring experimental reproducibility in oxidative phosphorylation inhibition studies (APExBIO).
    • CCCP is insoluble in aqueous buffers but dissolves in ethanol and DMSO at ≥16.23 mg/mL and ≥20.5 mg/mL, respectively, supporting flexible assay protocols (APExBIO).
    • No in vivo or clinical studies using CCCP have been reported to date; its use is restricted to in vitro research (APExBIO).
    • Activation of λ phage lytic promoters by CCCP in E. coli K-12 is RecA-dependent and requires auto-cleavable CI repressor and Cro function, illustrating CCCP’s role as an energy poison (APExBIO).

    This article extends the foundational overview in "CCCP: Defining a Mitochondrial Proton Gradient Uncoupler" by incorporating recent benchmarks from deep learning-enabled biomarker discovery in Alzheimer’s disease models.

    Applications, Limits & Misconceptions

    CCCP is deployed as a precision tool for disrupting mitochondrial proton gradients in the following contexts:

    • Studying mitochondrial metabolism and ATP synthesis dependency in cell lines and primary cultures.
    • Modeling neurodegenerative disease processes, including mitochondrial dysfunction in Alzheimer’s disease (Yan et al., 2025).
    • Validating mitochondrial biomarkers using live-cell imaging and machine learning quantification (Yan et al., 2025).
    • Induction of bacteriophage lytic cycles in prokaryotic systems by energy poisoning.
    • Screening for small molecules that rescue or exacerbate mitochondrial dysfunction.

    For a strategic roadmap on translational research, see "Redefining Mitochondrial Research: Strategic Use of CCCP …". This article updates the translational context by integrating the latest AI-driven diagnostic discoveries.

    Common Pitfalls or Misconceptions

    • CCCP is not suitable for in vivo or clinical use. No safety or efficacy data exist for humans or animal models (APExBIO).
    • Water-insolubility limits direct aqueous dilution. CCCP must be first dissolved in ethanol or DMSO before addition to cell culture media.
    • High concentrations (>20 μM) may induce non-specific toxicity. Optimal working range is typically 1–10 μM for mitochondrial assays (Yan et al., 2025).
    • Reversibility is time- and washout-dependent. Prolonged exposure may cause irreversible cell damage.
    • Not all cell types respond identically. Sensitivity to CCCP varies by cell line, metabolic state, and assay conditions.

    For troubleshooting and advanced workflow guidance, "CCCP: Precision Uncoupler for Mitochondrial Metabolism Re…" offers actionable protocols—this article clarifies AI-enabled assessment and recent purity benchmarks.

    Workflow Integration & Parameters

    Integration of CCCP into research workflows requires precise handling and storage:

    • Prepare stock solutions in ethanol or DMSO at manufacturer-recommended concentrations (≥16.23 mg/mL and ≥20.5 mg/mL, respectively).
    • Store solid CCCP at room temperature; avoid long-term storage of solutions to maintain compound integrity (APExBIO).
    • Typical working concentrations for mitochondrial membrane potential assays: 1–10 μM; validate empirically for each cell type and assay.
    • Monitor mitochondrial depolarization using fluorescent dyes (e.g., JC-1, TMRE) before and after CCCP addition.
    • Ensure rapid mixing and uniform dispersion in cell culture media; minimize DMSO/ethanol final concentration (<1%) to avoid solvent effects.
    • Wash out CCCP promptly to assess recovery and reversibility of mitochondrial function.

    For additional mechanistic background and disease-modeling applications, see "CCCP (carbonyl cyanide m-chlorophenyl hydrazine): Precisi…". This article extends those findings by providing new evidence on AI-driven readouts and experimental reproducibility.

    Conclusion & Outlook

    CCCP (carbonyl cyanide m-chlorophenyl hydrazine) is an established uncoupler of oxidative phosphorylation and a critical tool for dissecting mitochondrial function (internal article). APExBIO’s B5003 CCCP supports reproducible, high-fidelity research in mitochondrial metabolism, disease modeling, and biomarker discovery. The compound’s physicochemical stability and defined mechanism enable dynamic, non-invasive assessment of mitochondrial health in diverse experimental systems. As research advances in deep learning and live-cell imaging, CCCP will continue to play a foundational role in elucidating the links between mitochondrial dysfunction and systemic disease. For full product details and ordering, visit the CCCP (carbonyl cyanide m-chlorophenyl hydrazine) product page.